Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À帷 ħ¹ü À§¾Ï ȯÀÚ¿¡¼­ ¼ö¼ú ÈÄ º¹°­³» Cisplatin ÅõÀÔÀÇ Ä¡·á È¿°ú(ÈÄÇâÀû ¿¬±¸) Therapeutic Effect of the Intraperitoneal Cisplatin Installation (IPCI) in Advanced Gastric Carcinoma with Serosa Invasion Retrospective study

´ëÇѾÏÇÐȸÁö 2000³â 32±Ç 6È£ p.1015 ~ 1021
±èÇà¼ö, °ûÁøÈ£, ±è¿ëÈ£, ÀÌâȯ, À°Á¤È¯, ¿À¼ºÅÂ, ±èº´½Ä, ¹Ú°ÇÃá,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÇà¼ö ( Kim Haeng-Su ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ÀϹݿܰúÇб³½Ç

°ûÁøÈ£ ( Kwak Jin-Ho ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ÀϹݿܰúÇб³½Ç
±è¿ëÈ£ ( Kim Yong-Ho ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ÀϹݿܰú
ÀÌâȯ ( Lee Chang-Hwan ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ÀϹݿܰúÇб³½Ç
À°Á¤È¯ ( Yook Jeong-Hwan ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ÀϹݿܰú
¿À¼ºÅ ( Oh Sung-Tae ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ÀϹݿܰú
±èº´½Ä ( Kim Byung-Sik ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ÀϹݿܰú
¹Ú°ÇÃá ( Park Kun-Choon ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ÀϹݿܰúÇб³½Ç

Abstract


Purpose :We performed retrospective study to evaluate the preventive effect of intraperitoneal cisplatin installation (IPCI) on peritoneal recurrence after curative resection of advanced gastric cancer.

Materials and Methods :The effect of IPCI was evaluated in 297 advanced gastric carcinoma patients from January 1993 to December 1996. In IPCI group, 100 mg/body of cisplatin in one liter of saline was installed in peritoneal cavity before wound closure in operating room and drained out 2 hours later. Postoperative adjuvant chemotherapy with combination of 5-FU and cisplain was performed. 155 cases were treated by IPCI. Median follow-up period was 26 months.

Results :Out of 139 (46.8%) recurred cases, peritoneal, local and distant recurrences developed in 65 (37.8%) cases, 66 (38.4%) cases and 41 (23.8%) cases respectively. In univariated analysis for survival and recurrence, IPCI, T stage and N stage were significant prognostic factors. As regards to peritoneal recurrence, IPCI and T stage were significant factors. In multivariated survival analysis, as regards to recurrence, IPCI, T stage and N stage were significant prognostic factors. As regards to peritoneal recurrence, IPCI was the only significant independent prognostic factor.

Conclusion :We concluded that IPCI can effectively prevent peritoneal recurrence and overall recurrence and it shows marginal survival benefit in advanced gastric cancer patients with serosa invasion.

Å°¿öµå

Stomach neoplasm;Intraperitoneal cisplatin installation;Peritoneal recurrence;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS